Company Name: Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The company is engaged in developing dermatologic treatments. The company’s lead product candidate is designed to be used in the treatment of Seborrheic Keratosis legions and other types of cutaneous indications, including common warts.

Ticker Symbol: ACRS (NASDAQ)

Company Website: www.aclaristx.com

Headquarters: Malvern, PA